Overview


According to FutureWise analysis, the market for Aneurysm Coiling and Embolization Devices is expected to reach US$ 5.74 billion by 2031 at a CAGR of 9.32% over the forecast period of 2023-2031.

Aneurysm coiling and embolization devices represent a critical frontier in modern medical technology, addressing the complex challenge of treating intracranial aneurysms with a minimally invasive approach. These devices are pivotal in averting the potentially catastrophic consequences of aneurysm rupture, which can result in life-threatening subarachnoid hemorrhages or debilitating neurological impairments. The coiling procedure involves a carefully orchestrated process where a catheter is navigated through the blood vessels, typically from the femoral artery to the site of the aneurysm in the brain. Once in position, platinum coils are delicately deployed into the aneurysm sac, often possessing intricate shapes and varying sizes. These coils promote clotting within the aneurysm, effectively sealing it from average blood circulation and preventing rupture. Embolization, another technique, entails the utilization of an assortment of materials such as coils, stents, or liquid embolic agents. These materials are introduced into the aneurysm to obstruct blood flow, stimulating the formation of a stable clot and rendering the aneurysm inactive. The devices themselves are a testament to cutting-edge engineering and material science. They are designed with biocompatible materials to ensure compatibility with the human body and minimize adverse reactions. Moreover, the devices often incorporate advanced delivery systems that allow for precise placement within the intricate network of cerebral blood vessels, significantly reducing the risk of complications. The paradigm shift brought about by these devices is profound. The invasive nature of traditional open surgeries has given way to procedures that necessitate only small incisions, resulting in shorter hospital stays, less postoperative pain, and faster recuperation periods. 

Furthermore, the risk of infection and other complications associated with open surgeries is notably reduced. As the field of medical technology advances, aneurysm coiling, and embolization devices continue to evolve. Innovations in device design, materials, and imaging techniques ensure they are becoming increasingly influential and tailored to address a broader range of anatomical complexities. Nonetheless, selecting patients for these procedures is a careful process, with medical professionals meticulously assessing factors such as the size, location, and overall health of the patient before determining the most suitable treatment approach. Thus, these devices represent a remarkable fusion of medical expertise and technological sophistication, offering a transformative path forward in aneurysm treatment.

FutureWise Market Research has published a report that provides an insightful analysis of Aneurysm Coiling and Embolization Devices Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Aneurysm Coiling and Embolization Devices Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Stryker Corporation
  • Johnson and Johnson
  • Medtronic
  • Terumo
  • Penumbra
  • Microport Scientific Corporation
  • Abbott Vascular
  • W. L. Gore and Associates

(Note: The list of the major players will be updated with the latest market scenario and trends)

The Aneurysm Coiling and Embolization Devices Market is fueled by compelling drivers and notable restraints. On the driver's side, the market benefits from a rising global incidence of intracranial aneurysms, underscoring the urgency for effective treatment options. The relentless march of technological advancements in coiling and embolization device technology stands as a pillar of growth, consistently enhancing the safety and efficacy of these procedures and attracting medical professionals and patients alike. The appeal of minimally invasive interventions is another driving force, as these procedures offer reduced hospital stays, swifter recoveries, and diminished complication risks. The aging demographic landscape further propels this market, as the elderly population's vulnerability to aneurysms fuels the demand for sophisticated treatment.  Moreover, increasing healthcare expenditure, buoyed by robust awareness campaigns, facilitates broader access to advanced treatments. On the other hand, restraints are not to be underestimated. The high cost associated with devices and procedures can hinder market penetration, particularly in regions with limited resources or inadequate insurance coverage. The stringent regulatory approval processes within the medical device industry present a hurdle, potentially delaying the introduction of innovative devices. While these treatments are minimally invasive, they are not without risk, potentially giving pause to patients and healthcare providers. The need for more skilled professionals in this specialized field also poses a challenge, as does competition from alternative treatments and ethical and legal concerns. In this nuanced landscape, the Aneurysm Coiling and Embolization Devices Market advances with promise, counterbalanced by intricacies that necessitate strategic navigation.

By Product Type

  • Embolic Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents

By Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Units

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The Aneurysm Coiling and Embolization Devices Market displays distinct regional trends. North America and Europe dominates due to advanced healthcare infrastructure, awareness, and innovation. Asia-Pacific is a dynamic hub with growing investments and attention, while challenges like regulations persist. Latin America and the Middle East show potential but face economic and infrastructure hurdles.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Aneurysm Coiling
  • Embolization Devices market by product type, by application and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate the competitive landscape mapping- product launches, technological advancements, mergers and expansions

 

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aneurysm Coiling and Embolization Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aneurysm Coiling and Embolization Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aneurysm Coiling and Embolization Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aneurysm Coiling and Embolization Devices Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Embolic Coils
        2. Flow Diversion Devices
        3. Liquid Embolic Agents

  • 8.   Aneurysm Coiling and Embolization Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Units

  • 9.   North America Aneurysm Coiling and Embolization Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Aneurysm Coiling and Embolization Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Aneurysm Coiling and Embolization Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Aneurysm Coiling and Embolization Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Aneurysm Coiling and Embolization Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Stryker Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Johnson and Johnson
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Terumo
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Penumbra
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Microport Scientific Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Abbott Vascular
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. W. L. Gore and Associates
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients